Literature DB >> 17493005

The relationship of Helicobacter pylori positivity with age, sex, and ABO/Rhesus blood groups in patients with gastrointestinal complaints in Turkey.

Türkölmez Seyda1, Cayir Derya, Aydoğan Füsun, Korkmaz Meliha.   

Abstract

BACKGROUND: To determine the magnitude of Helicobacter pylori infection in patients with gastrointestinal complaints in Turkey.
METHODS: We studied 1680 patients with variable gastrointestinal complaints. The H. pylori infection status was determined using C-14 urea breath test (UBT). Overall, 1567 patients (548 male, 1019 female; age range 4-80 years, mean 29.37 +/- 17.30 years) were included in this study. The relationship between H. pylori positivity and age, sex, sociodemographic characteristic, blood groups, and gastrointestinal diagnosis was determined.
RESULTS: H. pylori positivity was found to be 68%. The difference in positivity rates between age groups 4-9 years and other groups was statistically significant (p = .001). H. pylori positivity was 67.7% in males and 68.2% in females (p = .865). H. pylori positivity was 72.1, 65.1, 70, and 68.4% in blood groups A, B, AB, and O (p = .703), and 68.9% and 76.3% in Rh (+) and Rh (-) blood subgroups, respectively (p = .292). There was no statistically significant difference between H. pylori positivity and gastrointestinal diagnosis (p = .980). There was significant association between increased number of household members and low socioeconomic status, and H. pylori positivity (p < .001). Living in rural and suburban area was significantly associated with H. pylori positivity compared with living in urban.
CONCLUSIONS: H. pylori infection positivity rate was 68% in symptomatic subjects in Turkey and the positivity rate was significantly lower at age 4-9 years than the other age groups. It was not related to gender, ABO, and Rh blood groups and gastrointestinal diagnosis. Low socioeconomic conditions and living in rural and suburban area were significantly associated with H. pylori positivity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17493005     DOI: 10.1111/j.1523-5378.2007.00500.x

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  12 in total

1.  Stool Antigen Testing, a Reliable Noninvasive Method of Assessment of Helicobacter pylori Infection Among Patients with Gastro-duodenal Disorders in Cameroon.

Authors:  Laure Brigitte Kouitcheu Mabeku; Mohamadou Bello Epesse; Stephane Fotsing; Roland Kamgang; Magloire Tchidjo
Journal:  Dig Dis Sci       Date:  2020-04-30       Impact factor: 3.199

Review 2.  Blood Groups in Infection and Host Susceptibility.

Authors:  Laura Cooling
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

Review 3.  Helicobacter pylori Infection in the general population: A Middle Eastern perspective.

Authors:  Hossein Khedmat; Reza Karbasi-Afshar; Shahram Agah; Saeed Taheri
Journal:  Caspian J Intern Med       Date:  2013

4.  Evaluation for Helicobacter pylori in Meckel's diverticulum by using real-time PCR.

Authors:  Ahmet Tuzun; Zulfikar Polat; Guldem Kilciler; Ilker Turan; Abdullah Kilic; Ayhan Ozcan; Ahmet Uygun
Journal:  Dig Dis Sci       Date:  2009-08-29       Impact factor: 3.199

5.  Do gender and age influence the frequency of Helicobacter pylori infection?

Authors:  Marinko Marušić; Karolina Majstorović Barać; Ante Bilić; Dragan Jurčić; Saša Gulić; Petra Grubić Rotkvić; Josip Bago
Journal:  Wien Klin Wochenschr       Date:  2013-10-22       Impact factor: 1.704

6.  Clarifying the relationship between ABO/Rhesus blood group antigens and upper gastrointestinal bleeding.

Authors:  Kadim Bayan; Yekta Tüzün; Serif Yilmaz; Mehmet Dursun; Fikri Canoruc
Journal:  Dig Dis Sci       Date:  2008-08-21       Impact factor: 3.199

7.  Relation between ABO blood groups and Helicobacter pylori infection in symptomatic patients.

Authors:  Mohamad Salih Jaff
Journal:  Clin Exp Gastroenterol       Date:  2011-09-19

8.  Effectiveness of ranitidine bismuth citrate and proton pump inhibitor based triple therapies of Helicobacter pylori in Turkey.

Authors:  Huseyin Alkim; Mustafa Iscan; Feriha Oz
Journal:  Libyan J Med       Date:  2011-09-08       Impact factor: 1.657

9.  Seroprevalence of Helicobacter pylori infection and its related risk factors in symptomatic patients in southern Ethiopia.

Authors:  Endale Tadesse; Deresse Daka; Demo Yemane; Techalew Shimelis
Journal:  BMC Res Notes       Date:  2014-11-24

10.  Feco-prevalence and risk factors of Helicobacter pylori infection among symptomatic patients at Dessie Referral Hospital, Ethiopia.

Authors:  Abdurahaman Seid; Wondmagegn Demsiss
Journal:  BMC Infect Dis       Date:  2018-06-07       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.